LCN2 and neoplasm: Lastly, it has been shown that tumour cells in CSF express the iron-binding protein lipocalin-2 (LCN2) and its receptor SCL22A17 to outcompete other cells, such as macrophages, for free iron and thus ensure tumour metabolism [142].